Hopefully my last nwbo post, and first in over a month. nwbo has been a waste of my time, which I'm finally fixing, but not without a few comments on top 25 posters and other matters.
flipper44 29516 posts. Any family, friends, neighbors to talk to? Shelter pet? Plants? Any life outside nwbo?
biosectinvestor 22274 - Pompous, arrogant, condescending, and wrong is no way to go through life.
sentiment_stocks 14099 - I wonder how many readers realize nwbo is the first stock you ever owned. That you couldn't understand financial statements until kindly bears helped you out.
exwannabe 12129 - Next time you think about nwbo, research a different stock. You'll be happier, healthier, wealthier.
hoffmann6383 11539 - one of my 2 blocks. Posts like a foul-mouthed 14 year old.
Doc logic 11148 - Consistently polite.
Sojourner55 9338 - Surprised you're in the top 10. Can't think of anything distinctive. So just good luck.
jdheart101 9019 - Hunting those meme stocks will eventually bite you in the ass.
HappyLibrarian 8911 - You moderate more evenly than you get credit for.
scotty3371 8514
sukus 7800
Poor Man - 7448 - Thank you for some desperately needed light humor.
marzan 7096 - I don't believe you, or anyone else here, has minions.
learningcurve2020 6845
ae kusterer 6426 - Endless flow of re-tweets. Apparently no original thoughts.
Dr Bala 6296 - I'm actually glad you're a 24/7/365 internet troll, because if you were really a doctor I would fear for your patients.
skitahoe 6105 - You seem like a nice guy, but please try to be less naive about believing things you WANT to be true.
pgsd 5872
vator 5729
longfellow95 5643 - longfellow long gone.
CaptainObvious 5593 - Contributes timely relevant data. Discussion would improve with more users like you.
anders2211 4858
GoodGuyBill 4487
Rkmatters 4446 - No posts in over a year. Thoughtful poster. Terrible predictor.
CrashOverride 4270 - Another foul-mouthed 14 year old. No one could possibly believe you know anything about investing.
A few outside the top 25:
Pyrrhonian - Only user to truly switch sides. His long 70+ page SeekingAlpha analysis of how CYTR's trial was a guaranteed success should be required reading to see how much can go wrong in amateur analysis.
Kabunishi - a true gentleman
iclight - You post angry, and take this way too personal. Apparently forget that a lot of times you're basically responding to a bot.
ATLnsider - Just because you can put wildly optimistic assumptions in Excel does not make them real.
abeta - oddly one reason I dug deeper into nwbo is that you were such a total a$$ on old yahoo MB.
Final thoughts:
There might be one more pump if nwbo ever gets around to submitting in the UK. Have a plan. If that gets the stock over $1, stick to your plan and be smart rather than greedy.
If nwbo does submit in the UK, I expect it to be rejected. Results are marginal once adjusted for nwbo advantages over competitors in full resection, KPS score, patient health, etc. No patient level data. Way too many warts on a 15+ year trial that went from P2 to P3, upsize, unexplained FDA halt, unbalanced enrollment, etc.
LP might still try to keep the saga going with the story that some change in FDA regs make the US a better bet. That could also be the excuse if they don't submit in the UK.
I doubt there is much speculative shorting. Not a sensible bet. Shorting is logical to hedge in-the-money warrants and "C" Preferred.
Naked shorting is fiction.
There is nothing remotely normal or desirable about having a key supplier owned by the CEO.
There is nothing remotely normal or desirable about a public company failing to have quarterly investor calls.
It is ridiculous to call something a "platform technology" when it has zero approved indications, and no current trials on other indications.
Taking 3 years from data lock to submit for approval is not normal. Apparently BP has valuable experience rather than just a checkbook.
Stock and options that you have granted yourself do not qualify as "skin in the game".
AI
